30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

ApiFix System Reaches 100-Patient Milestone in Scoliosis Correction -

The ApiFix® system for correction of Adolescent Idiopathic Scoliosis has been used in 100 patients, to date, at 12 sites in nine countries.

The device is implanted in a minimally invasive procedure, does not require fusion and is designed to retain spinal flexibility. The earliest patients are now at four years post-op. At 1- to 3-year follow-up in 50 adolescent scoliosis patients reported in mid-2015, the ApiFix system revealed substantial curve correction and no implant failure.

ApiFix expects to double the number of cases by the end of 2017.

The device received approval under the CE Mark in 1Q13, and ApiFix is preparing a submission to FDA for a Humanitarian Device Exemption.

Sources: ApiFix Ltd.; ORTHOWORLD Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.